Core issue
The father has bacteriologically confirmed pulmonary TB and has already missed
9 doses in
2 weeks. The central problem is not simply access to drugs, but
ensuring that every remaining dose is actually swallowed under the direct observation of a trained, responsible treatment supporter. Once a patient has demonstrated this degree of non-adherence, unsupervised or weakly supervised options reproduce the conditions that led to missed doses and increase the risk of treatment failure and drug resistance.
Why option 1 is the best arrangement
The BHS midwife is a trained health worker located within walking distance of the home, so the family does not need to pay daily transportation to the RHU. Having the midwife observe each daily dose provides
directly observed therapy without travel cost. The World Health Organization–endorsed DOT strategy requires that a health worker, community volunteer, or family member observe and record each dose to strengthen adherence
[3]. In this scenario, the midwife is the only option that combines training, accountability, and zero transportation cost.
The systematic review and meta-analysis by Wright et al. compared community-based DOT with clinic DOT and found that community-based delivery can achieve TB treatment outcomes comparable to conventional clinic-based observation
[1]. In this case, the BHS functions as the community-based DOT site, and the midwife serves as the community health worker. This arrangement removes the fare barrier while preserving the essential element of direct observation.
Why the other options are unsafe
Option 2, taking doses at the RHU only on days the family can pay the fare, keeps treatment intermittent. Intermittent or irregular ingestion of antituberculous drugs is a major driver of
acquired drug resistance and treatment failure. The Cochrane review by Karumbi and Garner emphasizes that incomplete treatment may lead to failure of cure and development of drug resistance
[3]. Relying on the family’s ability to pay creates exactly the kind of irregularity that must be avoided.
Option 3, having the
12-year-old son observe each dose, places a child in the role of treatment supporter for an adult. A school-age child is not a trained or responsible treatment supporter, and this arrangement also shifts a clinical responsibility onto a minor. While family members can serve as DOT observers in some programs
[3], the appropriateness of the observer depends on maturity, training, and reliability. A
12-year-old does not meet that standard for supervising an adult’s TB treatment.
Option 4, giving a
1-month supply for self-administration, abandons direct observation entirely. The patient has already missed
9 doses under conditions of unsupervised or poorly supervised intake. The Cochrane reviews comparing DOT with self-administration consistently note that DOT is a strategy to improve adherence because many patients do not complete treatment on their own
[3]. Providing a month of medication without observation would repeat the very circumstances in which non-adherence occurred.
Pathophysiology and clinical reasoning
Pulmonary TB requires at least
6 months of continuous treatment
[3]. The intensive phase, usually the first
2 months, is designed to rapidly kill actively multiplying bacilli and reduce infectivity. The continuation phase then eliminates persisting organisms to prevent relapse. Missing
9 doses during this period means the serum drug levels fall below the threshold needed to suppress mycobacterial growth, allowing surviving bacilli to resume replication. When drug exposure is intermittent,
mycobacteria with spontaneous resistance mutations are selectively favored, which is the biologic basis for acquired drug resistance.
Because the father is a construction worker living in a one-room house with closed windows and three young children, the public health stakes are high. Continued sputum positivity from interrupted treatment prolongs household transmission risk. The
3-year-old and
7-year-old are especially vulnerable to progression from latent infection to active disease. Ensuring reliable, observed treatment is therefore both a clinical and a household infection-control priority.
Comparison of DOT arrangements
| Arrangement | Observer | Travel cost | Adherence protection | Judgment |
|---|
| BHS midwife observes daily dose | Trained health worker | None, within walking distance | Strong, direct observation every dose | Best choice |
| RHU only on days fare is affordable | RHU staff | Variable, often unaffordable | Weak, intermittent dosing | Risk of failure and resistance |
| 12-year-old son observes at home | Child, untrained | None | Unreliable, inappropriate responsibility | Not acceptable |
| 1-month supply, self-administered | None | None | Absent, repeats non-adherence conditions | Unsafe |
Watch out! The presence of a nearby health facility does not by itself solve the adherence problem. The key is that the observer must be trained, responsible, and accessible without cost. Among the choices, only the BHS midwife satisfies all three conditions.
Key point! After multiple missed doses, the priority is to restore
daily directly observed therapy through the most accessible trained provider. Removing the transportation barrier while maintaining observation is the central clinical decision in this scenario.
References (research sources)
- [1]
Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness.Meta-analysis/systematic reviewWright CM, Westerkamp L, Korver S, Dobler CC (2015) · DOI: 10.1186/s12879-015-0945-5
- [3]
Directly observed therapy for treating tuberculosis.Research articleKarumbi J, Garner P (2015) · DOI: 10.1002/14651858.CD003343.pub4